CLINICAL_TRIALS
research
· 2007-06-25
Clinical Trial Update: Maximum Targeted Ablation of Atrial Flutter [Phase 4]
Summary
Phase 4 clinical trial update on maximum targeted ablation for atrial flutter; the current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Atrial Flutter | Phase 4 | Status: UNKNOWN